Through genome-wide expression profile analysis, hypoxia-inducible protein 2 (HIG2) has previously been identified as an oncoprotein involved in development/progression of renal cell carcinoma (RCC). The gene discussed is HILPDA; the disease is hereditary clear cell renal cell carcinoma.